Eisai Announces Real-World Data on the Effectiveness of HALAVEN® (eribulin mesylate) for the Treatment of Patients with Metastatic Breast Cancer (mBC) Published in Advances in Therapy – PRNewswire
CONTEXT: Publication of a retrospective chart review on the effectiveness of Halaven (eribulin mesylate) in metastatic breast cancer | One of the limitations of this study is that detailed safety Continue Reading
